UK CMA raises vehicle refinish concerns in Phase 1 review of AkzoNobel-Axalta merger
The competition authority found problems only in UK vehicle refinish coatings supply, and the companies plan to offer the divestment already agreed with the European Commission.
The UK Competition and Markets Authority (CMA) issued its Phase 1 decision on the proposed AkzoNobel-Axalta merger on 11 November. The regulator identified competition concerns in one area only: the supply of vehicle refinish coatings in the UK.
AkzoNobel and Axalta intend to offer the CMA the same remedy they have already agreed with the European Commission. It involves divesting AkzoNobel's European vehicle refinish business, including its UK operations.
The companies continue to expect the transaction to close by early 2027. The source material does not give further detail on the CMA's reasoning, the timetable for the remedy process or the terms of the divestment.
Why it matters
- The CMA's concerns are narrow, limited to UK vehicle refinish coatings supply, and it found no issues elsewhere in the combined business.
- Aligning the UK remedy with the one agreed with the European Commission points to a consistent approach across both jurisdictions.
- Closing remains targeted for early 2027, though that depends on the CMA's response to the proposed remedy, which the source does not describe.
Company's press release (SEC filing): Akzo Nobel Nv ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.
MacroGenics reports $288M cash and 2028 runway, putting B7-H3 ADC MGC026 in head and neck cancer first
Xenetic reports Q3 loss, advances all-stock Santersus deal and doses first DNase I CAR-T patient
Longeveron seeks FDA meeting after ELPIS II miss and starts strategic alternatives review
Silence Therapeutics narrows Q3 loss as Merck KGaA deal and divesiran data take centre stage
Theriva Sells SYN-004 Antibiotic-Enzyme Assets to Biossil Labs for $350,000 Upfront
